Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 15 INDUSTRY 13 NIH 4 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Sezary Syndrome 1 Ovarian Neoplasms 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Esophageal Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

Gemcitabine 18 Cisplatin 14 Paclitaxel 9 Vinblastine 7 Methotrexate 7 Radiotherapy 6 Doxorubicin 6 Carboplatin 6 Fluorouracil 4 Surgical Procedures, Operative 3 Mitomycin 3 Filgrastim 3 BCG Vaccine 3 Gefitinib 2 Docetaxel 2 Cystectomy 2 valrubicin 1 rubitecan 1 romidepsin 1 piritrexim 1 merphos 1 lonafarnib 1 durvalumab 1 avelumab 1 atezolizumab 1 Watchful Waiting 1 Urination 1 Transurethral Resection of Bladder 1 Taxes 1 Radiotherapy, Conformal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Urinary Bladder Neoplasms × atezolizumab × Clear all

NCT04134000 2024-05-21

BladderGATE

Fundacion Oncosur

Phase 1 Unknown

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡